Managing GERD Symptoms

Initial Pharmacologic Management

The American Gastroenterological Association recommends starting with a 4-8 week trial of once-daily proton pump inhibitor (PPI) therapy taken 30-60 minutes before a meal for patients presenting with troublesome heartburn or regurgitation without alarm symptoms 1, 2, 3
PPIs are the most effective first-line treatment for GERD, superior to H2-receptor antagonists and antacids, according to the American College of Gastroenterology 4
Any commercially available PPI can be used initially, with selection guided by insurance coverage and cost, as suggested by the Clinical Gastroenterology and Hepatology guidelines 2, 3

Weight loss for overweight or obese patients is the single most effective lifestyle intervention with proven benefit on esophageal pH profiles and symptoms, as recommended by the Gastroenterology guidelines 4, 1, 5
Elevate head of bed by 6-8 inches for patients with nighttime heartburn or regurgitation to improve esophageal pH time, according to the Clinical Gastroenterology and Hepatology guidelines 4, 1, 5
Avoid lying down for 2-3 hours after meals to reduce esophageal acid exposure, as suggested by the Gastroenterology guidelines 4, 5

Provide standardized education covering GERD as a physiologic process involving transient lower esophageal sphincter relaxations, as recommended by the Clinical Gastroenterology and Hepatology guidelines 1, 2, 3
Emphasize PPI safety to address common patient concerns about long-term use, according to the Clinical Gastroenterology and Hepatology guidelines 1, 2, 3

Titrate to the lowest effective PPI dose or consider on-demand therapy with H2-blockers/antacids for patients without erosive esophagitis at baseline, as suggested by the Clinical Gastroenterology and Hepatology guidelines 1, 5
Continue PPI indefinitely for patients with erosive esophagitis or severe GERD phenotype, according to the Clinical Gastroenterology and Hepatology guidelines 1

Require more intensive therapy with twice-daily PPI for 8-12 weeks minimum for extraesophageal symptoms, as recommended by the Praxis Medical Insights guidelines 5
Empiric PPI trial is not optimal for isolated extraesophageal symptoms due to multiple contributing mechanisms, according to the Clinical Gastroenterology and Hepatology guidelines 2, 3